1[1]Dunn FW, Roux MH, Farhadion F, et al. HR - 720, a novel angiotentin receptor antagonist inhibits the angiotentin Ⅱ - indices tropic effects, fibronectin release and vascular smooth muscle cell in vitro. J Pharmacol Exp Ther, 1997,280: 447.
2[2]Dikawa T, Freeman M, Lom, et al. Modulation of plasminogen activator inhibitor- 1 in vivo, a new mechanism for the anti - fibrotic effect of renin angiotentin inhibition. Kidney Int, 1997,51:164.
3[3]Zhou A, Yu L, Li J, et al. Renal protective effects of blocking the intrarenal renin - angiotensin system angiotensin Ⅱ type Ⅰ receptor antagonist compared with angiotensincowerting enzyme inhibitor. Hypertens Res, 2002, 23: 391.
4[4]Carla Zo ja, Biolscid, Roberfa DD, et al. The renoprotective properties of angiotensin - converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotentin Ⅱ: evidence based on comparative studies with a receptors antagonist. Am J Kidney,1997,29(2) :254.
2Remuzzi G,Bertani T.Is glomerulosclerosis a consequence of a ltered glomerular permeability to macromolecules?Kidney Int,1990,38:384.
3Thomas ME.Contribution of proteinuria to progressive renal injury:Conse quences of tubular uptake of fatty acid bearing albumin.Am J Nephron,1993(3):385 -386.
4Donadio JV Jr,Torres VE,Velosa JA,et al.Idiopathic membranous glomerulo pathy:The nature history of untreated patients.Kindey Int,1998(33):708-715.
5Hunt LP,Short CD,Mallick NP.Progonstic indictors in patients presents w ith neprotic syndrome.Kidney Int,1998(34):382-388.
6Vriesendorp R,Donker AJM,de Zeeuw D.Effects of non-seroidal anti-inflam matory drugs on proteinuria.Am J Med,1986(81 suppl)84-93.
